Silverback Therapeutics shuts down oncology program, plans to lay off 27% of workforce by Charlotte Schubert on March 31, 2022April 1, 2022 at 7:59 am Silverback Therapeutics will lay off 27% of its workforce and close its oncology program, the Seattle company announced Thursday in its fourth quarter earnings report. The company reported disappointing clinical… Read More